Pfizer

Open: 27.1 Close: 27.29 Change: 0.19

How to get informed about Pfizer Company Inc quickly using an AI.

The game is changing. There is a new strategy to evaluate Pfizer fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pfizer are: Pfizer, revenue, company, quarter, adjust, expect, report, and the …

Concept Map

Semantic Network

Stock Summary

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. Pfizer offers medicines and vaccines in various therapeutic areas. The company also provides biosimilars for chronic immune and inflammatory diseases.

Today's Summary

Pfizer posted a surprise adjusted fourth-quarter profit as the company lost less revenue than expected. Pfizer lost $3.37 billion in the final quarter of 2023 after booking a nearly $5 billion profit in the same quarter the prior year. Analyst consensus on Pfizer is a Moderate Buy with an average price target of $31.

Today's News

Pfizer posted a surprise adjusted fourth-quarter profit as the companys declining Covid business lost less revenue than expected. The company sees fewer-than-expected returned Paxlovid doses as an encouraging sign that use of the drug increased in the fourth quarter. Pfizer also reiterated its full-year 2024 guidance. Pfizer reported a Q4 adjusted EPS of $0.10 versus a consensus loss of £0.22. Pfizer guided for 2024 revenue growth in a range that is flat to up 5%, with revenue in the range between $58.5 billion and $61.5billion. New drugs expected to bring in $20 billion in revenue. Pfizer–BioNTech COVID-19 vaccine is an mRNA vaccine produced by the German company BioNTech and the American company Pfizer. Pfizer and BioNTecs overlooked third partner will distribute the vaccine in China. Pfizer stays the course on 2024 outlook after delivering better earnings than Wall Street forecast. Pfizer lost $3.37 billion in the final quarter of 2023 after booking a nearly $5 billion profit in the same quarter the prior year. Pfizers total revenue fell 41% in the quarter to $14.25 billion. Pfizer reported a quarterly revenue of $13.23 billion and a GAAP net loss of $2.38 billion. Analyst consensus on Pfizer is a Moderate Buy with an average price target of $31.63, a 16.80% upside from current levels. Pfizer Inc. (PFE) stock price, quote, news & analysis. pfizer inc. (pfe) stock. (pfizer) stock market news from jan. 30, 2024: Dow closes higher; Pfizer, starbucks, gm, ups, ups and more market movers; bitcoin prices jump. Pfizer has reaffirmed its full-year 2024 guidance, which was initially provided on 13 December 2023. Pfizer aims to increase its RSV market share by establishing vaccination as a year-round discussion Pfizer is looking for Directors of Marketing Analytic Project Managers (APM) Pfizer, a global leader in the biopharmaceutical industry is continuously seeking fresh new talent. Your in-depth knowledge and financial skills will keep our products in production and our innovators innovating. Pfizers purpose is to deliver breakthroughs that change patients lives. Pfizer CEO Albert Bourla sits down with Anchor Julie Hyman to discuss all things Pfizer from its recent quarterly earnings, its acquisition of Seagen, and what lies ahead for the company and his optimism for the future. Pfizer reported a Q4 adjusted EPS of $0.10 versus a consensus loss of $(0.22) Pfizer expects R&D expenses of $11 billion-$12 billion for 2024. Pfizers 200-day moving average sits at $33.77, according to Benzinga Pro.

Stock Profile

"Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York."

Keywords

Are looking for the most relevant information about Pfizer? Investor spend a lot of time searching for information to make investment decisions in Pfizer. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pfizer are: Pfizer, revenue, company, quarter, adjust, expect, report, and the most common words in the summary are: pfizer, vaccine, stock, best, covid19, news, report, . One of the sentences in the summary was: Pfizer posted a surprise adjusted fourth-quarter profit as the company lost less revenue than expected. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #pfizer #vaccine #stock #best #covid19 #news #report.